Engineered exosome-mediated delivery of functionally active miR-26a and its enhanced suppression effect in HepG2 cells [Erratum]
Authors Liang G, Kan S, Zhu Y, Feng S, Feng W, Gao S
Received 26 June 2018
Accepted for publication 26 June 2018
Published 7 August 2018 Volume 2018:13 Pages 4507—4508
Liang G, Kan S, Zhu Y, et al. Int J Nanomedicine. 2018;13: 585–599.
On page 586, the 1st heading, right hand column should read “Materials and methods” instead of “Patients and methods”.
Read the original article.
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]